Review
Open access
Oct 2026
Novel strategies against drug-resistant tuberculosis: a comprehensive review from molecular mechanisms to clinical translation
In 2023, an estimated 13% of worldwide deaths resulting from antimicrobial resistance (AMR) were due to drug-resistant TB (DR-TB). The World Health Organization (WHO) documented a dramatic, sixfold increase in the number of patients treated with 6-month all-oral (BPaLM) regimens, from 5,653 patients in 2023, to 34,00...
Ming-Xiao Yao, Bo Pang, Ling Tian et al.
· Frontiers in Immunology · 0 citations